Definitive Diagnostics' mission is to improve cancer survival rates and quality of life for cancer patients through accurate, earlier diagnosis, and eliminate wasteful downline testing.
Our patented platform identifies, with high precision, some of the most prevalent (breast, lung, colorectal) and aggressive (pancreatic, ovarian) cancers, and many cancer subtypes.
Definitive Diagnostics' patented technology relies on abundant cancer-related proteins found in blood that signal, through a series of proprietary biomarker patterns, the presence of cancer across all stages.
Independent audits support 97%-99% sensitivity and specificity across cancer types, with equivalent success rates at Stage 1. 98% accuracy in determining TOO, i.e., specific cancer type (when one is present) with overall minimal false positive/negative rates (1-3%).
Definitive Diagnostics is currently completing development of a series of AI-enhanced diagnostic screening tests, automated for global scalability, and independently validated.
Company Details
- Employees
- 4
- Founded
- -
- Address
- S Euclid Ave, St. Louis,missouri,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.definitivedx.bio
- Keywords
- Oncology Diagnostics, AI-Enhanced Biomarker Platform, MCED, Subtype Differentiation, MCD, Liquid Biopsy, Blood Test, Early Cancer Detection.
- HQ
- St. Louis, Missouri
Definitive Diagnostics, Inc. Questions
Definitive Diagnostics, Inc.'s website is http://www.definitivedx.bio
Definitive Diagnostics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/definitivediagnostics
Definitive Diagnostics, Inc. has
4 employees.
View email and phone details for 4
employees at Definitive Diagnostics, Inc..
Definitive Diagnostics, Inc.'s industry is
Biotechnology Research
Definitive Diagnostics, Inc.'s top competitors are
Éo-Vision Ai,
Sequoia Sciences Llc,
Nuleaf Tech, Inc,
Niura,
Vitalis Regenerative Materials,
Loopini,
Definitive Neurodiagnostics,
Subconscious Ai,
Emt Consulting,
Athlitix.
Definitive Diagnostics, Inc.'s categories are Biotechnology Research
Definitive Diagnostics, Inc.'s founding year is 2023
